UNSPSC 51351525: Nomegestrol acetate

This classification denotes a therapeutic progestin C23H30O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83J78V5W05, chemically known as 6-methyl-3,20-dioxo-19-norpregna-4,6-dien-17-yl acetate, but more generally known as nomegestrol acetate, which bears US NIH Compound Identifier 91668. European Medicines Agency schedules Nomegestrol acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03449MIG.

Most nations, for tariff and trade purposes, schedule nomegestrol acetate under HS 29372300 and SITC 54153. As of Q4 2014, NOMEGESTROL ACETATE remains US FDA's Preferred Term for this commodity. Nomegestrol acetate bears US NLM identifiers UMLS ID C0132749 and NCI Concept Code C87244. SMILES: CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@H]4C1=CC(=O)CC4.

UNSPSC 51351525 Nomegestrol acetate is a Commodity code tracking procurement of this specific progestin pharmaceutical active ingredient by state and local health agencies, typically for inclusion in hormonal contraceptive formulations or related medical preparations. State and local governments procure nomegestrol acetate primarily through public health departments, Medicaid agencies, state pharmaceutical benefit managers, and correctional health systems that manufacture, compound, or source finished contraceptive products.

The source provided contains no records of recent state and local contract opportunities under this code, and therefore does not support characterization of issuing-body concentration, geographic activity, or representative solicitations at this time.